Vol. 4 No. 3 (2017): Volume 4 Issue 3 2017

Articles

• Short-term Cardio-Vascular Risk Score Changes in Type 2 Diabetic Patients on Empaglifozin: A Real-Life Clinical Experience

  Alessandra Fusco, Sara Colarusso, Marco Piscopo, Maria Rosaria Improta, Marco Corigliano

  46-56

  • pdf

  DOI: https://doi.org/10.17140/HROJ-4-141

• Cardioprotective Effect of Losartan Alone or in Combination with Remote Ischemic Preconditioning on the Biochemical Changes Induced by Ischemic/Reperfusion Injury in a Mutual Prospective Study with a Clinical and Experimental Animal Arm

  Ehab S. EL Desoky, Ayman K. M. Hassan, Safaa Y. Salem, Sabah A. Fadil, Amira F. Taha

  57-65

  • pdf

  DOI: https://doi.org/10.17140/HROJ-4-142

• Three-Dimensional Printing in Cardiovascular Disease: Verification of Diagnostic Accuracy of 3D Printed Models

  Zhonghua Sun

  66-70

  • pdf

  DOI: https://doi.org/10.17140/HROJ-4-143

• Where are Cell-Based Therapies Heading? Current Limitations and Future Directions

  Gen Suzuki, Rebeccah F. Young, Harue Suzuki

  71-77

  • pdf

  DOI: https://doi.org/10.17140/HROJ-4-144

• Chest Pain Without Coronary Artery Obstruction and Calcification in Young Women May Indicate Left Ventricular Diastolic Dysfunction

  Riri Watanabe, Masao Moroi, Mitsuaki Isobe

  78-86

  • pdf

  DOI: https://doi.org/10.17140/HROJ-4-145